Switch theme
Sign up to access all valuation multiples
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
2003
3.4K+
LTM Revenue $1.3B
LTM EBITDA $94.2M
$1.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Guardian Pharmacy Service has a last 12-month revenue (LTM) of $1.3B and a last 12-month EBITDA of $94.2M.
In the most recent fiscal year, Guardian Pharmacy Service achieved revenue of $1.2B and an EBITDA of -$43.4M.
Guardian Pharmacy Service expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Guardian Pharmacy Service valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | XXX | $1.2B | XXX | XXX | XXX |
| Gross Profit | $254M | XXX | $244M | XXX | XXX | XXX |
| Gross Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBITDA | $94.2M | XXX | -$43.4M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | -4% | XXX | XXX | XXX |
| EBIT | -$8.6M | XXX | -$62.9M | XXX | XXX | XXX |
| EBIT Margin | -1% | XXX | -5% | XXX | XXX | XXX |
| Net Profit | -$44.0M | XXX | -$87.3M | XXX | XXX | XXX |
| Net Margin | -3% | XXX | -7% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Guardian Pharmacy Service's stock price is $21.
Guardian Pharmacy Service has current market cap of $1.3B, and EV of $1.4B.
See Guardian Pharmacy Service trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.4B | $1.3B | XXX | XXX | XXX | XXX | $-0.67 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Guardian Pharmacy Service has market cap of $1.3B and EV of $1.4B.
Guardian Pharmacy Service's trades at 1.1x EV/Revenue multiple, and -31.2x EV/EBITDA.
Equity research analysts estimate Guardian Pharmacy Service's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Guardian Pharmacy Service has a P/E ratio of -30.4x.
See valuation multiples for Guardian Pharmacy Service and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 14.4x | XXX | -31.2x | XXX | XXX | XXX |
| EV/EBIT | -157.8x | XXX | -21.5x | XXX | XXX | XXX |
| EV/Gross Profit | 5.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | -30.4x | XXX | -15.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 32.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialGuardian Pharmacy Service's last 12 month revenue growth is 6%
Guardian Pharmacy Service's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Guardian Pharmacy Service's rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Guardian Pharmacy Service's rule of X is 24% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Guardian Pharmacy Service and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | -4% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 30% | XXX | XXX | XXX |
| Rule of 40 | 12% | XXX | 3% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 24% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Guardian Pharmacy Service acquired XXX companies to date.
Last acquisition by Guardian Pharmacy Service was XXXXXXXX, XXXXX XXXXX XXXXXX . Guardian Pharmacy Service acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Guardian Pharmacy Service founded? | Guardian Pharmacy Service was founded in 2003. |
| Where is Guardian Pharmacy Service headquartered? | Guardian Pharmacy Service is headquartered in United States of America. |
| How many employees does Guardian Pharmacy Service have? | As of today, Guardian Pharmacy Service has 3.4K+ employees. |
| Who is the CEO of Guardian Pharmacy Service? | Guardian Pharmacy Service's CEO is Mr. Fred Burke. |
| Is Guardian Pharmacy Service publicy listed? | Yes, Guardian Pharmacy Service is a public company listed on NYS. |
| What is the stock symbol of Guardian Pharmacy Service? | Guardian Pharmacy Service trades under GRDN ticker. |
| When did Guardian Pharmacy Service go public? | Guardian Pharmacy Service went public in 2024. |
| Who are competitors of Guardian Pharmacy Service? | Similar companies to Guardian Pharmacy Service include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Guardian Pharmacy Service? | Guardian Pharmacy Service's current market cap is $1.3B |
| What is the current revenue of Guardian Pharmacy Service? | Guardian Pharmacy Service's last 12 months revenue is $1.3B. |
| What is the current revenue growth of Guardian Pharmacy Service? | Guardian Pharmacy Service revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Guardian Pharmacy Service? | Current revenue multiple of Guardian Pharmacy Service is 1.1x. |
| Is Guardian Pharmacy Service profitable? | Yes, Guardian Pharmacy Service is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Guardian Pharmacy Service? | Guardian Pharmacy Service's last 12 months EBITDA is $94.2M. |
| What is Guardian Pharmacy Service's EBITDA margin? | Guardian Pharmacy Service's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Guardian Pharmacy Service? | Current EBITDA multiple of Guardian Pharmacy Service is 14.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
